Defining filter design space for validation of continuous virus filtration

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Comapny Name: Pall Life Sciences

Address: 25 Harbour Park Drive, Port Washington, NY

Phone: +1 (516) 484 3600

Email: [email protected]

Pall Life Sciences, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule drugs. The unmatched portfolio of traditional and single-use products is backed by custom service support and is both scalable and easily integrated to support processes from R&D through to commercial phases of production, including formulation/filling. As a core driver of the continuous bioprocessing movement, Pall Life Sciences has remained focused on delivering innovative semi- and fully continuous solutions, with the goal of continuously improving bioprocesses for a safer, healthier future.

Defining filter design space for validation of continuous virus filtration

Please log in for more information